Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal JKBM (JURNAL KONSEP BISNIS DAN MANAJEMEN)
Bayu Putro Wibisono
Unknown Affiliation
Decision Sciences, Operations Research & Management

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Competitive Advantage in Indonesian Pharmaceutical Raw Material Companies: Effect of External Integration, Agility, and Innovativeness Bayu Putro Wibisono; RR. Ratih Dyah Kusumastuti
JKBM (JURNAL KONSEP BISNIS DAN MANAJEMEN) Vol. 10 No. 2 (2024): JKBM (JURNAL KONSEP BISNIS DAN MANAJEMEN) MEI
Publisher : Universitas Medan Area

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.31289/jkbm.v10i2.11728

Abstract

Indonesian pharmaceutical raw material companies have an important position in the supply chain of drug products because 90-95% of pharmaceutical raw materials are still imported. Therefore, it is very important to measure the ability of pharmaceutical raw material companies to maintain the pharmaceutical supply chain in Indonesia. The aim of this study is to evaluate and examine the impact of External Integration (EIN), Supply Chain Agility (SCA), and Supply Chain Innovativeness (SCI) on compe-titive advantage (KK). This study also explored the mediation role of SCA and SCI in the relationship between EIN and KK. This study involved 84 Pharmaceutical raw material companies and used quanti-tative method with partial-least squares structural equation modeling (PLS-SEM) as the analysis tool. The results showed that EIN had a positive and significant effect on SCA, SCI, and KK. Furthermore, the findings indicated that SCA positively and significantly influenced KK. Additionally, SCA played a mediating role in the correlation between EIN and KK. However, the effect of SCI on KK and its mediating role were not supported by the data. This indicates that the capabilities of EIN and SCA play an important role in im-proving the KK of pharmaceutical raw material companies in Indonesia
Co-Authors RR. Ratih Dyah Kusumastuti